Insider filing
Traded Oct 2 · filed 3 days later
Derivative exercise or conversion — not an open-market buy.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Sep 9, 2026 · Filed Sep 10, 2026
Bristol Myers Squibb's Chief Med Offr,Head of Dev sold $403K of Bristol Myers Squibb shares. The filing does not indicate a pre-arranged trading plan.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market sale
Code S — open-market or private sale
~$403,498
Shares × reported transaction price
41 days after results of Jul 30, 2026, 50 days before results of Oct 29, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $64.41 on Sep 9, 2026, 51% above its 52-week low and 5% below its high, after a 1% rise over the previous 30 trading days
52-week range $42.60 (Oct 29, 2025) to $68.09 (Sep 3, 2026), 86% of the way up, from 251 adjusted closes. 30 trading days earlier: $63.60 on Jul 28, 2026. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
FDA approved Zenbexus on Aug 13, 2026, 27 days before this trade.
New drug application approved. Active ingredient: Iberdomide Hydrochloride. From openFDA. Dates only; no link between the two is implied
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −0.9% | −0.3% | −0.6% |
| 30 days | −9.5% | +1.8% | −11.3% |
Past results only. Not a forecast.
Insider filing
Traded Oct 2 · filed 3 days later
Derivative exercise or conversion — not an open-market buy.
Insider filing
Traded Oct 2 · filed 3 days later
Routine share withholding; mechanical by default.
Insider filing
Traded Oct 2 · filed 3 days later
Derivative exercise or conversion — not an open-market buy.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.